PricingLoginNewsroom
Vol. II — No. 184Remarkable People · Exceptional CompaniesToday's Edition

3dna-platform

(2)
AllCompaniesPeopleStoriesProducts
Legend
Brian McVeigh Built a Career in the Space Between Science and the Deal
Founder · Executive · Operator

Brian McVeigh Built a Career in the Space Between Science and the Deal

After 25 years at GSK and more than 100 transactions, the Philadelphia biotech executive made a founder's bet: the next leap in genetic medicine may depend less on the cargo than on the way it travels.

brian-mcveigh · code-biotherapeuticsRead →
Company
The $85 Million Bet That a DNA Scaffold Can Make Gene Therapy Re-Dosable
Health

The $85 Million Bet That a DNA Scaffold Can Make Gene Therapy Re-Dosable

Code Biotherapeutics is trying to turn DNA into the FedEx network for genetic medicine. Its modular 3DNA scaffold promises bigger payloads, precise addresses and repeat delivery - but the public evidence is still preclinical.

biotechnology · genetic-medicineRead →